Siemens sells Water Technologies business to US private equity firm for €640mn

Siemens sells Water Technologies business to US private equity firm for €640mn

NEWS ...Continued from front page “Pentair has consistently grown its pump business in the region for many years and we are excited about this next ph...

81KB Sizes 0 Downloads 190 Views

NEWS ...Continued from front page “Pentair has consistently grown its pump business in the region for many years and we are excited about this next phase of development. The ability to manufacture locally will enable us to provide our customers a broader array of value-added solutions while also enhancing our ability to serve them effectively,” said Gary Witt, president of Pentair Flow Technologies. Pentair employs more than 1200 people within the Middle East, at manufacturing, services and sales office facilities. For further information, visit www.pentair.com

focusing our water business on solutions in line with our electro technical core competencies in automation and drive technologies,” said Siegfried Russwurm, member of Siemens’ managing board and CEO of the company’s Industry Sector. The sale does not include Siemens Water Solutions, which is part of the Siemens Energy -iV̜À]Ê"ˆÊEÊ>ÃÊLÕȘiÃÃ]Ê«ÀœÛˆ`ˆ˜}ÊÜ>ÌiÀÊ and wastewater treatment solutions to the oil and gas market. Products staying with Siemens include the Brise dissolved gas flotation pump. For further information, visit www.siemens.com and www.aeainvestors.com

Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: David Hopwood Subscription Information

Siemens sells Water Technologies business to US private equity firm for E640mn

S

iemens has agreed to sell its Water Technologies business unit to New York-based private equity specialist AEA Investors LP in a deal valued at E640 million (see Pump Industry Analyst, December 2012). The sale includes Siemens Water Technologies’ municipal, industrial and services water and wastewater treatment operations and assets. The existing Water Technologies management, including CEO Dr Lukas Loeffler, will remain under AEA ownership, and the business will continue to focus on municipal and industrial water and wastewater treatment equipment and services. “We look forward to a new chapter of increased entrepreneurship, flexibility and growth for Water Technologies,” said Dr Loeffler. “Together with AEA, we will continue building on our wide range of enduring brands and advanced water and wastewater treatment technologies to help our customers more cost-effectively meet their water needs now and in the future.” “We are excited to be partnering with one of the leaders in the global water industry and are supportive of management and their plan to continue to grow the business,” said AEA managing partner Brian Hoesterey. Siemens will now focus its water business on automation and drive solutions for the operation of water and sewage treatment and seawater desalination plants. “At Siemens, we will in the future be 16

Pump Industry Analyst

Torishima adds pump service facility in India

T

orishima Pump Mfg Co Ltd has officially opened a new service facility in Bangalore, India to maintain boiler circulation pumps. The Japanese company has received orders for nearly 300 boiler circulation pumps from India since 2007. These highly specialised pumps play an important role in thermal power plants. There are nearly 1000 other Torishima pumps in India. Torishima has plans to offer maintenance services for these pumps in the future and to promote energy-saving services such as improving efficiency and upgrading pump and plant performance. Torishima has also recently opened a liaison office in Seoul, South Korea.

For further information, visit www.torishima.co.jp

DAB inaugurates new production plant in Hungary

D

AB Pumps has officially opened its new 5000 m2 production facility in Nagykanizsa, Hungary. The new factory is strategically important for Eastern markets and will provide new production capacity for the Italian pump company. DAB Pumps expects to produce one million more electric pumps in the next five years. With this new production facility, DAB now has 17 bases on five continents, including sales offices and production facilities. For further information, visit www.dabpumps.com

An annual subscription to Pump Industry Analyst includes 12 issues and online access for up to 5 users. Prices: 1291 for all European countries & Iran US$1448 for all countries except Europe and Japan ¥171 700 for Japan (Prices valid until 31 December 2013) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.pumpindustryanalyst.com Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.

Digitally Produced by Mayfield Press (Oxford) LImited 12979

November 2013